A leader in enterprise immune system technology
Darktrace has raised €200M across 5 funding rounds from 11 investors, most recently a Series D+ round in Sep 2018. Based in Cambridge, UK; founded 2013; active in Cybersecurity. Acquired by Thoma Bravo in 2024. Data as of 7 Aug 2026.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2018-09-26 | Series D+ | €42M | 1011 Ventures,KKR,Vitruvian Partners | View deal → |
| 2017-09-05 | Series D+ | €63M |
| Insight Venture Partners,KKR & Co. (Kohlberg Kravis Roberts & Co.),Summit Partners,TenEleven Ventures |
| View deal → |
| 2016-07-01 | Series C | €58M | Hoxton Ventures,KKR,SoftBank,Summit Partners,TenEleven Ventures | View deal → |
| 2015-07-01 | Series B | €20M | Summit Partners | View deal → |
| 2015-03-01 | Series A | €16M | Hoxton Ventures,Invoke Capital,Talis Capital | View deal → |
